Risk Factor and Clinical Outcomes of Coronavirus Disease 2019 (COVID -19) Patients in TAK Province, Thailand
Objective: To describe the association of clinical characteristics, clinical progression, and outcome of COVID-19 patients in TAK province, Thailand
Methods: This retrospective cohort study included patients who were diagnosed with COVID-19 in Tak province, Thailand from June 1, 2021 to December 31, 2021.
Results: The statistical analysis was done on the records of 15,442 patients who underwent RT-PCR of SARS-CoV-2 detection at Tak province during the fourth wave of the outbreak. 53.9% of patients were diagnosed asymptomatic. The overall mortality rate among patients with COVID-19 in this study was 1.81%. Patients with ages over 60 years was associated with increased risk of pneumonia (aOR 5.16, 95% CI 4.52-5.89; P < 0.001) and death (aOR 22.09, 95% CI 12.66-38.53, P < 0.001). Myanmar were also significantly associated with pneumonia (aOR 1.15, 95% CI 1.00-1.33, P < 0.001) and death (aOR 1.99, 95% CI 1.44-2.78, P < 0.001). Chronic Kidney Disease (aOR 3.84, 95% CI 2.31-6.38, P < 0.001) and dyspnea (aOR 4.54, 95% CI 3.27-6.31, P < 0.001) were associated with increased odds of death as well as the presence of more than one comorbidity (aOR 2.87, 95% CI 1.99-4.14, P < 0.001). The previous receipt of vaccination regardless of partially (aOR 0.14, 95% CI 0.08-0 .27; P < 0.001) or fully vaccination (aOR 0.08, 95% CI 0.03-0.19; P < 0.001) was associated with lower odds of mortality.
Conclusions: Determining high-risk COVID-19 infected patients can help in the design of appropriate measures and proper management strategies. Ongoing mass vaccination efforts is still an absolutely priority for Thai and non-Thai citizens as a human right to health.